{
    "meeting_annotations": [
        {
            "speaker": "Danae Schulz",
            "timestamp": "00:00-00:02",
            "transcript": "strategies there.",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "William Witola",
            "timestamp": "00:04-00:49",
            "transcript": "Yeah, that that's a good question. Um, so I I did mention about uh, you know, using what I called uh self-assembling nanoparticles. So if if for example, we talk about toxoplasma, which is intracellular. So if you have to deliver these peptides that activate uh, uh, pyroptosis for example, they have to be able to enter the cells.",
            "speaking duration": 45,
            "nods_others": 1,
            "smile_self": 10.0,
            "smile_other": 10.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "William Witola",
            "timestamp": "00:49-01:06",
            "transcript": "And so these nanoparticles, uh, some of them have platforms that will expose. So you you basically, um, engineer, they coding sequences of those peptides in this platform.",
            "speaking duration": 17,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "William Witola",
            "timestamp": "01:06-01:37",
            "transcript": "And then the platform has its own uh sequences that allow uh creation of this uh small a little molecule um with those peptides exposed on its surface. ",
            "speaking duration": 31,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "William Witola",
            "timestamp": "01:37-02:22",
            "transcript": "And then there are certain features on this uh nanoparticle that allows it to uh readily penetrate uh cell membranes and get into the cytoplasm or even into the uh nucleus. That way then you can actually uh target your peptides to the actual uh pathogen in the cell. So that that can be like a delivery mechanism. And uh if you do it that way, it's like the RNA vaccine that's being used against uh uh COVID, uh whereby you're not just introducing peptides, but you are introducing coding sequences that once they get into the cell, you know, uh they'll express uh, you know, the actual proteins or the actual peptides in uh significant amounts.",
            "speaking duration": 45,
            "nods_others": 0,
            "smile_self": 10.0,
            "smile_other": 10.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Danae Schulz",
            "timestamp": "02:22-02:29",
            "transcript": "Okay, thanks. And then so Giselle for the interference, have you thought about this?",
            "speaking duration": 7,
            "nods_others": 0,
            "smile_self": 28.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Giselle Medina",
            "timestamp": "02:30-03:19",
            "transcript": "Yeah, so we have used uh in the past the adenovirus um platform. So these are replication defective adenovirus um that can be propagated in um a cell substrates like heck 293 cells. And what you do is basically you clone your favorite uh let's say interferon or your interference stimulated gene that previously has been tested to know that it has some inhibitory uh function. And the good thing about the adenovirus is that you can um introduce this to the animal uh by injection subcutaneously or intramuscularly. And the only thing is that the the actual agent, so the molecule has to be able to be secreted so that at least uh it's um it kind of becomes systemic so that it can provide protection to the animal. ",
            "speaking duration": 49,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Raising Hand",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Giselle Medina",
            "timestamp": "03:19-03:25",
            "transcript": "So in the case of interferon, we know that this is kind of the the universal uh inhibitory uh molecule for not just viruses, uh also for um parasites as well.",
            "speaking duration": 6,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Raising Hand",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Giselle Medina",
            "timestamp": "03:25-04:21",
            "transcript": "Um, I think the the something that is universal is to activate these um pathogen uh recognizing molecules. So those can be activated by different ways even utilizing pieces of the bacteria itself so that the cells can be activated and then induce uh the interferon. But interferon using the adenovirus uh platform has been very successful for some viruses. I'm not sure for others, yes.",
            "speaking duration": 56,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Raising Hand",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "04:25-04:35",
            "transcript": "So I'd like to go back to uh a couple of things that Dr. Schultz and Dr. Huet had shared earlier particularly around um cast nine and CRISPR, some of these technologies.",
            "speaking duration": 10,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "04:35-04:56",
            "transcript": "Um, uh I I think one of you described this as kind of like um I don't know, almost like hiding hiding the key to the door under the mat somewhere so that only the right things could get into uh a cell and maybe I'm distilling that down a little too fine.",
            "speaking duration": 21,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "04:56-05:15",
            "transcript": "Um and and in others that was was a lot more um uh proactive at at really designing um designing something would go in and effectively either turn off a response or turn on a response. I I think that was some of your thoughts, Dr. Schultz.",
            "speaking duration": 19,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "05:15-05:24",
            "transcript": "Um can can you expand on some of those?",
            "speaking duration": 9,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Danae Schulz",
            "timestamp": "05:24-06:03",
            "transcript": "Um, yeah, I think so assuming it seems like a difficult challenge to figure out what is the relevant gene that lets the things hop, right? So that seems like a very difficult problem, but if we could find that gene, then maybe with these adenovirus or nanoparticle um delivery mechanisms that folks have been talking about, we can deliver the genomic information to code for the RNA that will and the cast nine protein that will go in and target that gene, um perhaps in these domestic animals before it's hopped to people.",
            "speaking duration": 39,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Danae Schulz",
            "timestamp": "06:03-06:16",
            "transcript": "So that was kind of my idea if we could get the delivery to get the CRISPR cast nine to the right to the viral target um to inactivate the viral replication mechanisms, which I guess uh Angad might be great at telling us what would be the correct target.",
            "speaking duration": 13,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "06:31-07:00",
            "transcript": "Just to elaborate a bit more of on what uh Dr. Schultz was saying, uh people are trying to develop CRISPR cast based systems that target uh sort of RNA replication for coronaviruses.",
            "speaking duration": 29,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "07:00-07:17",
            "transcript": "And so typically what's been tested there to the best of my knowledge uh is uh the RNA polymerase uh and the RNA capping enzymes which tend to be uh essential for the propagation of the virus.",
            "speaking duration": 17,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "07:17-07:45",
            "transcript": "But most of them are sort of post cellular entry uh mechanisms. And so uh the the pathogen has to get within the cell and then one has to target the host cell to actually uh prevent the replication from occurring.",
            "speaking duration": 28,
            "nods_others": 0,
            "smile_self": 10.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "07:45-07:50",
            "transcript": "And so uh the problems are similar to what uh uh Dr. Medina uh described, you know.",
            "speaking duration": 5,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "07:50-07:52",
            "transcript": "So given you describe, why don't you write that down?",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "07:52-08:17",
            "transcript": "Um sure. I I have written a whole bunch of things if everyone wants to look at it because uh I'm not sure if everything is relevant, but uh uh I would probably write targeted delivery of uh I've probably written down as well. It's already there actually. Targeted delivery of small molecules and oligonucleotides uh to intracellular pathogens and viruses.",
            "speaking duration": 25,
            "nods_others": 0,
            "smile_self": 12.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk",
            "timestamp": "08:20-08:29",
            "transcript": "Richard, since you're on and you're probably going to pop back out, can you tell us again what the timing is? So till when do we have?",
            "speaking duration": 9,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Richard Wiener",
            "timestamp": "08:29-08:48",
            "transcript": "I think we're extending it to 11:55. I was trying to communicate with Andrew because we started about 10 minutes late, so that's what I'm going on, but Andrew got um he's got to uh facilitate another group, so he hasn't given me an answer back, but I think it's going to be 11:55.",
            "speaking duration": 19,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Richard Wiener",
            "timestamp": "08:48-08:53",
            "transcript": "So you guys have a few more minutes to talk and then do the summary. But we're going to broadcast a 10 minute warning.",
            "speaking duration": 5,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Richard Wiener",
            "timestamp": "08:53-08:54",
            "transcript": "So that will that will be good. you'll know.",
            "speaking duration": 1,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "08:54-08:57",
            "transcript": "Okay, so I got why don't you continue what you have so far just to brief everybody.",
            "speaking duration": 3,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "08:57-09:01",
            "transcript": "Can I can I screen share?",
            "speaking duration": 4,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk",
            "timestamp": "09:01-09:03",
            "transcript": "Um why don't you try it?",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "09:04-09:21",
            "transcript": "I I okay, it seems like I can. Give me a second. Let me just screen share what I have got here. Okay.",
            "speaking duration": 17,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta",
            "timestamp": "09:21-09:24",
            "transcript": "Can you see my screen?",
            "speaking duration": 3,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The current slide is titled \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The slide lists several bullet points related to therapeutic and inhibitory strategies, including using platforms for screening small molecule scaffolds, RNA therapeutics, target pathogen entry blocking receptors, CRISPR-based strategies, transcriptomics profiling, and inhibitors for essential enzymes. A list of participants is on the right side of the slide."
        },
        {
            "speaker": "Peter Dorhout",
            "timestamp": "09:24-09:24",
            "transcript": "Yeah.",
            "speaking duration": 0,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The current slide is titled \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The slide lists several bullet points related to therapeutic and inhibitory strategies, including using platforms for screening small molecule scaffolds, RNA therapeutics, target pathogen entry blocking receptors, CRISPR-based strategies, transcriptomics profiling, and inhibitors for essential enzymes. A list of participants is on the right side of the slide."
        },
        {
            "speaker": "Danae Schulz",
            "timestamp": "09:24-09:24",
            "transcript": "Yes.",
            "speaking duration": 0,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "Yes",
            "screenshare": "Yes",
            "screenshare_content": "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The current slide is titled \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The slide lists several bullet points related to therapeutic and inhibitory strategies, including using platforms for screening small molecule scaffolds, RNA therapeutics, target pathogen entry blocking receptors, CRISPR-based strategies, transcriptomics profiling, and inhibitors for essential enzymes. A list of participants is on the right side of the slide."
        }
    ]
}